ARCHIVES

Zwelling Moves to Legacy Community Health

This article is from The Cancer Letter archive.

Vol. 39 No. 29 | July 19, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Funding opportunities listed.

September 17, 2004

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001